ALGS FY 2022 Earnings — Aligos Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALGSAligos Therapeutics, Inc.

$45M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+219.0% YoY

Gross Profit

$14M100.0% margin

Operating Income

-$98M-701.7% margin

Net Income

-$96M-690.6% margin

EPS (Diluted)

$-2.25

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$80M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$147M

Total Liabilities

$43M

Stockholders' Equity

$104M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$4M	+219.0%
Gross Profit	$14M	$4M	+219.0%
Operating Income	-$98M	-$128M	+24.0%
Net Income	-$96M	-$128M	+25.2%